Iterum Therapeutics Plc (ITRM) Tops Q3 EPS by 58c
Tweet
Share
E-mailGet Alerts ITRM Hot Sheet
Join SI Premium – FREE
Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q3 EPS of ($0.30), $0.58 better than the analyst estimate of ($0.88).
For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Coty (COTY) Misses Q4 EPS by 1c, offers outlook
- Unifi, Inc. (UFI) Misses Q4 EPS by 11c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
